Epigenetic biomarkers for disease susceptibility and preventative medicine

Michael K. Skinner
DOI: https://doi.org/10.1016/j.cmet.2023.11.015
IF: 29
2024-02-07
Cell Metabolism
Abstract:This review is focused on the epigenetic biomarkers for disease susceptibility, which are distinct from epigenetics of disease etiology or progression. The development of efficient epigenetic biomarkers for disease susceptibility, before the development of pathology, will facilitate a paradigm shift from reactionary medicine to preventative medicine.
cell biology,endocrinology & metabolism
What problem does this paper attempt to address?